---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-005916"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2024-02-12T23:59:59+00:00"
generated_at: "2026-06-06T04:09:40.185021+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oragenics CEO Kimberly Murphy departs; Pope named Exec Chairman, Redmond Interim PEO

## Summary
- CEO Kimberly Murphy separated from company Feb 12, 2024, per mutual agreement; remains on board of directors.
- Charlie Pope appointed Executive Chairman, Michael Redmond named Interim Principal Executive Officer immediately.
- Separation provides benefits under employment agreement for termination without cause; no disagreement cited.

## SEC filing metadata
- accession: 0001493152-24-005916
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2024-02-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-005916
- JSON: https://secwatch.observer/filing/0001493152-24-005916.json
- Plain text: https://secwatch.observer/filing/0001493152-24-005916.txt

## Key facts
- Executive change
  Michael Redmond was appointed as Interim Principal Executive Officer at ORAGENICS INC.
  - Action: appointed
  - Role: Interim Principal Executive Officer
  source text: In addition, effective February 12, 2024, the Board appointed Michael Redmond, the Company’s President, as the Company’s Interim Principal Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm
- Executive change
  Charlie Pope was appointed as Executive Chairman at ORAGENICS INC.
  - Action: appointed
  - Role: Executive Chairman
  source text: The Board will provide direction to the Company during this transition in management, with Charlie Pope, the Company’s Chairman of the Board, serving, on an interim basis, as Executive Chairman, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm
- Executive change
  Kimberly Murphy was terminated as Chief Executive Officer at ORAGENICS INC.
  - Action: terminated
  - Role: Chief Executive Officer
  source text: On February 12, 2024, Oragenics, Inc. (the “Company”) and Kimberly Murphy, the Company’s Chief Executive Officer, entered into a mutually agreeable Separation Agreement (the “Separation Agreement”), pursuant to which Ms. Murphy’s employment with the Company terminated effective February 12, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.